1. Introduction {#s0005}
===============

Normal human and animal diet contains a wide range of various pro-oxidants formed during food preparation for cooking. It includes oxidized polyunsaturated fatty acids, oxysterols, nitrites, nitrates, heavy metals, mycotoxins and many other organic pollutants. These harmful substances are found in food in low levels; however, various combinations of these pro-oxidants in food are considered to be the source of free radical production in the gastrointestinal tract (GIT). Therefore effective antioxidant protection in the GIT is needed to maintain gut health and this protection is based on food derived or supplemented antioxidants ([@b0140], [@b0145]).

Berberine is an isoquinoline alkaloid, present in root and shoot systems of clinically important medicinal plants ([@b0155]). Berberine based products are widely applied in traditional medicine ([@b0165]). It has been known to have a wide range of pharmacological activities due to its non-toxic effect on humans ([@b0160]).

Many studies were carried out to use berberine against several diseases for the in vivo mammalian system ([@b0040], [@b0105], [@b9000]). Moreover, Previous studies showed that, berberine has a wide range of antioxidant activities including activation of the antioxidant enzyme ([@b0130]).

This study aims to test the effect of berberine treatment in enhancing the antioxidant status within mouse jejunum tissue.

2. Materials and methods {#s0010}
========================

2.1. Animals {#s0015}
------------

Twelve male Swiss albino mice, *Mus musculus* (9--11 weeks) were allocated randomly into two groups with 6 mice per group. The first group is considered as the control group which received saline. The second group was daily treated with 10 mg/kg berberine chloride (Sigma Company, St. Louis, MO, USA) for five successive days via oral gavaging using an epigastric tube. The experiment was approved by state authorities of Zoology Department at King Saud University. The used dose is in agreement with previous studies on cytotoxicity measurements ([@b0155], [@b0065]).

2.2. Sample collection {#s0020}
----------------------

Animals were killed by cervical dislocation at day 5 p.i. Jejunum tissue was separated and washed several times with ice cold sterile phosphate buffer saline and divided into different portions.

2.3. Immunohistochemical staining of apoptosis and apoptotic score {#s0025}
------------------------------------------------------------------

Jejunum was isolated and cut into small pieces, then fixed in 10% neutral buffered formalin. After fixation, specimens were dehydrated in ethanol then, embedded in paraffin wax. Jejunum was sectioned to 5 μ thickness. Jejunum sections were tested for apoptotic changes in their villi using the TUNEL Apoptosis detection kit (GenScript, USA). The test is based on detection of fragmented DNA in the nucleus during apoptosis. Biotinylated nucleotide is labeled at the DNA 3′-OH ends using terminal deoxynucleotidyl transferase (TDT). Then, horseradish peroxidase labeled streptavidin (Streptavidin-HRP) is bound to these biotinylated nucleotides, which detect the peroxidase substrate, H~2~O~2~, and 3,3′-diaminobenzidine (DAB) solution staining the apoptotic nuclei dark brown color. Sections were then counterstained with hematoxylin solution for 1 min before the final processing of slides ([@b0045]). Apoptotic score was determined via counting the average number of apoptotic cells for ten better-orientated villous crypt units (VCU). Results were presented as the mean number of apoptotic cells per ten VCU.

2.4. Preparation of tissue homogenate {#s0030}
-------------------------------------

Pieces of jejunum were weighed then immediately homogenized in ice-cold phosphate buffered saline then centrifuged at 2000*g* × 15 min at 4 °C to give a final yield of (10% w/v) jejunal homogenates that were kept at −20 °C until use.

2.5. Oxidative damage biomarkers in jejunal homogenates {#s0035}
-------------------------------------------------------

Oxidized proteins were determined via the estimation of protein carbonyl content through the formation of labeled protein hydrazone derivatives using 2,4-dinitro phenyl hydrazine ([@b0090]), while, malondialdehyde was determined via the reaction with thiobarbituric acid in an acidic medium and high temperature yielding a colored product with a color intensity directly proportional to the amount of MDA at 534 nm ([@b0110]). In addition, hydrogen peroxide level was measured after the reaction with peroxidase enzyme, and with 3,5-dichloro-2-hydroxybenzensulfonic acid and 4-aminophenazone to form a chromophore with color intensity directly proportional to the amount of hydrogen peroxides in the test samples at 540 nm ([@b0005]). Moreover, nitrite/nitrate levels were determined via the formation of nitrous acid diazotise sulfanilamide in an acidic medium and the products were coupled with N-(1-naphthyl) ethylenediamine. The formed azo dye appeared bright reddish-purple in color that can be measured at 540 nm ([@b0015]).

TNF-α level and iNOs activity were determined using antigen antibody interaction in 96-microplate wells coated with specific monoclonal antibodies. Tumor necrosis factor-α was detected via solid phase sandwich enzyme linked immunosorbent assay, while inducible nitric oxide synthase activity was determined via competitive enzyme immunoassay (ALPCO Diagnostics, USA).

2.6. Antioxidant biomarkers in jejunal homogenates {#s0040}
--------------------------------------------------

Jejunal reduced glutathione level was determined colorimetrically via precipitation of proteins using tungstate sulfuric acid solution and the formation of a yellow color after reaction with DNTB ([@b0120]), while, the activity of glutathione peroxidase was determined kinetically depending on the catalyzing potential of GPX to reduce H~2~O~2~ and to oxidize reduced glutathione forming oxidized glutathione (GSSG) which in turn is reduced by glutathione reductase and NADPH forming NADP^+^ resulting in a decreased absorbance of solution at 340 nm. This decrease in absorption is directly proportional to GPX activity ([@b0115]). Also, total antioxidant capacity of jejunum tissue was determined colorimetrically via its activity to eliminate certain amounts of exogenously added H~2~O~2~. Residual amounts of H~2~O~2~ are enzymatically determined yielding colored products ([@b0080]). To determine the catalase activity, we used the method of [@b0005] which is based on the catalytic activities of catalase on a known amount of H~2~O~2~ for a certain time, and then reaction is stopped using a catalase inhibitor. The remaining amounts of H~2~O~2~ are determined colorimetrically in the presence of peroxidase enzyme and DHBS and aminophenazone to form a chromophore with the color intensity inversely proportional to the amount of catalase in the original sample.

2.7. Statistical analysis {#s0045}
-------------------------

Statistical analysis was carried out by using an unpaired Student's *t-*test. The obtained data were analyzed by MS Excel 2007 (Microsoft, Rochester, NY, USA) and SigmaPlot 2011 (Systat Software, Inc., Chicago, IL, USA).

3. Results {#s0050}
==========

Berberine treatment caused a significant reduction in the number of apoptotic cells (*P* ⩽ 0.05) within the jejunum tissue from 15.5 ± 2.3 to 8.3 ± 2.6 apoptotic cell/10 VCU ([Figs. 1](#f0005){ref-type="fig"} and [S1](#s0065){ref-type="sec"}).Figure 1Berberine induced reduction of apoptotic cell number within jejunum villous tissue in laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.

Upon oral administration of berberine to mice, a great enhancement of the antioxidant system within the jejunum tissue occurred. The total antioxidant capacity of jejunum tissues was raised by more than two fold ([Table 1](#t0005){ref-type="table"}). Also, reduced glutathione level was increased to 1.8 μmol/g ([Table 1](#t0005){ref-type="table"}). In addition, the antioxidant enzyme GPX was duplicated ([Table 1](#t0005){ref-type="table"}) and that of CAT activity was increased by more than two fold ([Table 1](#t0005){ref-type="table"}).Table 1Effect of berberine administration on jejunal glutathione peroxidase activity, catalase activity and reduced glutathione and total antioxidant capacity in laboratory mice.Glutathione peroxidase (mU/g)Reduced glutathione (μmol/g)Catalase (U/g)Total antioxidant capacity (mM/g)Control86.5 ± 12.11.3 ± 0.150.3 ± 0.071.2 ± 0.16BBR-treated147.8 ± 10.9[⁎](#tblfn1){ref-type="table-fn"}1.8 ± 0.11[⁎](#tblfn1){ref-type="table-fn"}0.79 ± 0.25[⁎](#tblfn1){ref-type="table-fn"}2.6 ± 0.3[⁎](#tblfn1){ref-type="table-fn"}[^1][^2]

Oxidative damage biomarkers in the infected jejunum tissue were significantly decreased after berberine treatment. Oxidized protein level was decreased by more than 50% ([Fig. 2](#f0010){ref-type="fig"}). In addition, nitrite/nitrate level was reduced to 302 ± 52 μmol/g ([Fig. 3](#f0015){ref-type="fig"}). Malondialdehyde and hydrogen peroxide contents were decreased to 25.6 nmol/g and 3.0 mM/g, respectively after berberine treatment ([Figure 4](#f0020){ref-type="fig"}, [Figure 5](#f0025){ref-type="fig"}). Also, the activity of the pro-inflammatory cytokine (TNF-α) and inducible nitric oxide synthase (iNOs) was decreased from 233.6 pg/g and 46.2 pmol/g to 168 pg/g and 32.4 pmol/g, respectively ([Figure 6](#f0030){ref-type="fig"}, [Figure 7](#f0035){ref-type="fig"}).Figure 2Berberine induced reduction of oxidized protein level within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.Figure 3Berberine induced reduction of nitrite/nitrate level within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.Figure 4Berberine induced reduction of lipid peroxidation products within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.Figure 5Berberine induced reduction of hydrogen peroxide level within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.Figure 6Berberine induced reduction of the pro-inflammatory cytokine (TNF-α) level within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.Figure 7Berberine induced reduction of inducible nitric oxide synthase activity within jejunum tissue of laboratory mice, *Mus musculus*. All values are mean ± SD. ^\*^Significant against control non-treated group at *P* ⩽ 0.05.

4. Discussion {#s0055}
=============

Pro-oxidants cannot be avoided in our food but we need to make sure that they are made by consumption of naturally formed antioxidants ([@b0145]). Antioxidants are essential for the gastrointestinal tract (GIT) to prevent lipid peroxidation. Also, antioxidant enzymes are needed in the intestinal mucosa to fight the induced oxidative damage ([@b0135]). Disturbance of the antioxidant system of the GIT could lead to various diseases as cells become more susceptible to infections by various microorganisms or the loss of their function in food absorption.

Experimental mice treated with berberine showed a great enhancement in the antioxidant status of their intestinal tissue. The activity of glutathione peroxidase and catalase enzymes was elevated, the glutathione level reduced and the total antioxidant capacity was also increased ([Table 1](#t0005){ref-type="table"}). Also, lipid peroxidation and protein oxidation processes were significantly diminished as revealed by the decreased amounts of malondialdehyde and protein carbonyl contents after berberine treatment ([Figure 2](#f0010){ref-type="fig"}, [Figure 4](#f0020){ref-type="fig"}. Moreover, hydrogen peroxide level was significantly reduced by about half of its value in control non-treated mice ([Fig. 5](#f0025){ref-type="fig"}). Finally, berberine effectively down-regulated nitric oxide pathway of inflammation as revealed by the decreased amounts of the pro-inflammatory cytokine (TNF-α) ([Fig. 6](#f0030){ref-type="fig"}), decreased activity of inducible nitric oxide synthase enzyme ([Fig. 7](#f0035){ref-type="fig"}) and reduced nitrite/nitrate levels within the jejunum tissue ([Fig. 3](#f0015){ref-type="fig"}).

Berberine was found to have a great capacity for quenching different free radicals such as DPPH, O~2~^−^, NO^−^ and OH^−^ ([@b0060], [@b0130]). It could decrease the formation of malondialdehyde in cultured rat hepatocytes with prevention capacity on the depletion of glutathione ([@b0010], [@b0060], [@b0150]). It also caused downregulation of the gene expression ratio of inflammatory biomarkers such as TNF-α and iNOs ([@b0025], [@b0070], [@b0075], [@b0095], [@b0050]). In addition, berberine has a wide range of antioxidant activities including activation of the antioxidant enzyme systems of SOD, CAT, GST and GPX, with conservation activities of non-enzymatic antioxidant levels ([@b0130], [@b0050]).

BBR protective activities against oxidative and cytotoxic damage occur via activation and/or suppression of different cellular pathways. It could inhibit inducible cyclooxygenase-2 (COX-2) over production through the activation of Peroxisome proliferator-activated receptor-gamma (PPARγ) pathway ([@b0055]), and suppress β-phosphorylation processes leading to diminished production of IL-1β and TNF-α ([@b0085]). In addition, its inhibitory effect of nitric oxide production and iNOs expression occurs via AMP-activated protein kinase sensitive pathway ([@b0130]). It was also found to inhibit ROS production through the inhibition of NADPH-oxidase mediated O~2~^−^ release ([@b0130]). Moreover, it caused the activation of redox sensing transcription factor Nrf2 and inhibition of NF-κβ dependent proinflammatory mediator's production of iNOs, COX-2 and TNF-α ([@b0020]).

Apoptosis in the gastro intestinal system is vitally essential, where constant and rapid renewal of intestinal cells is in progress providing normal function holding tissue homeostasis. In addition, many factors contribute to apoptosis including the elevated reactive oxygen and nitrogen intermediates and inflammatory cytokines within cells ([@b0125], [@b0100]).

Results of the current study show that berberine treatment of normal mice induced protection of villous epithelial cells from apoptotic changes as it caused a decrease in the number of apoptotic cells by about 50% (Figs. [1](#f0005){ref-type="fig"} and [S1](#s0065){ref-type="sec"}). This prevention of apoptosis may be due to the downregulatory effects of berberine on Bax/Bcl-2 gene expression ratio ([@b0030], [@b0035], [@b0050], [@b0105]).

Collectively, our data show that berberine treatment induced a significant enhancement of intestinal health in laboratory mice as revealed by decreasing apoptotic changes and reducing oxidative damage biomarkers with great activation of antioxidant biomarkers. So, it is recommended to use berberine in food or drug mixtures to enhance the intestinal health status.

Appendix A. Supplementary data {#s0065}
==============================

Supplementary Fig. S1Berberine induced reduction of apoptosis within jejunum tissue of laboratory mice, *Mus musculus*. (A) Control untreated jejunum. (B) Berberine treated mice jejunum. The arrow head refers to apoptotic cells. Sections were stained with TUNEL Apoptosis method. Scale bar = 50 μm
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[^1]: All values are mean ± SD.

[^2]: Significant against non-treated control group at *P* ⩽ 0.05.
